Diagnostic Value of Serum Heparin Binding Protein, Blood Lactic Acid Combined with hs-CRP in Sepsis and Its Relationship with Prognosis

Hongsong Ma, Huasheng Liu, Changyu Wu, Lieping Huang, Hongsong Ma, Huasheng Liu, Changyu Wu, Lieping Huang

Abstract

Objective: To explore the diagnostic value of serum heparin binding protein (HBP), blood lactic acid (Lac) combined with high-sensitivity C- reactive protein (hs-CRP) in sepsis and its relationship with prognosis.

Methods: The clinical data of 127 patients with sepsis from March 2019 to March 2021 in our hospital were retrospectively analyzed. 120 outpatients undergoing physical examination in the same period in our hospital were selected as the control group. According to the severity of the disease, 127 sepsis patients were divided into the mild sepsis group (n = 45), severe sepsis group (n = 53), and septic shock group (n = 29). According to the clinical prognosis, the patients were divided into the survival group (n = 96) and death group (n = 31). Serum HBP, Lac, and hs-CRP levels were measured in all subjects. The ROC curves of the subjects were drawn to analyze the predictive value of serum HBP, Lac, and hs-CRP for the prognosis of sepsis patients.

Results: The levels of serum HBP, Lac, and hs-CRP in the sepsis group were higher than those in the control group (P < 0.05). With the increase of the severity of sepsis, serum HBP, Lac, and hs-CRP levels of patients gradually increased (P < 0.05). The levels of serum HBP, Lac, and hs-CRP in the death group were higher than those in the survival group (P < 0.05). The AUC of serum HBP, Lac, and hs-CRP for predicting the prognosis of sepsis patients was 0.858 (95% CI: 0.763-0.953), 0.694 (95% CI: 0.589-0.799), and 0.843 (95% CI: 0.759-0.927). The AUC of serum HBP, Lac combined with hs-CRP for predicting the prognosis of sepsis patients was 0.961 (95% CI: 0.000-1.000).

Conclusion: The levels of serum HBP, Lac, and hs-CRP in patients with sepsis were significantly increased and increased with the severity of sepsis. Serum HBP, Lac, and hs-CRP have a good value in predicting the prognosis of patients with sepsis and worthy of clinical application.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Copyright © 2021 Hongsong Ma et al.

Figures

Figure 1
Figure 1
The predictive value of serum HBP, Lac, and hs-CRP on the prognosis of patients with sepsis.

References

    1. Salomão R., Ferreira B. L., Salomão M. C., Santos S. S., Azevedo L. C. P., Brunialti M. K. C. Sepsis: evolving concepts and challenges. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas . 2019;52(4):p. e8595. doi: 10.1590/1414-431X20198595.
    1. Barroqueiro E. S., Prado D. S., Barcellos P. S., et al. Immunomodulatory and antimicrobial activity of babassu mesocarp improves the survival in lethal sepsis. Evidence-based Complementary and Alternative Medicine: eCAM . 2016;2016:7. doi: 10.1155/2016/2859652.2859652
    1. Hoyert D. L., Xu J. Deaths: preliminary data for 2011. National Vital Statistics Reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System . 2012;61(6):1–51.
    1. Genga K. R., Russell J. A. Update of sepsis in the intensive care unit. Journal of Innate Immunity . 2017;9(5):441–455. doi: 10.1159/000477419.
    1. Stjärne Aspelund A., Hammarström H., Inghammar M., et al. Heparin‐binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients. American Journal of Transplantation . 2018;18(2):444–452. doi: 10.1111/ajt.14458.
    1. Fisher J., Russell J. A., Bentzer P., et al. Heparin-binding protein (HBP) Shock . 2017;48(3):313–320. doi: 10.1097/shk.0000000000000862.
    1. Niu T., Liu Y., Zhu F., Ma J., Gao J. Time-resolved fluorescent immunoassay-based combined detection of procalcitonin, C-reactive protein, heparin binding protein, and serum amyloid A1 to improve the diagnostic accuracy of early infection. Journal of Clinical Laboratory Analysis . 2019;33(2) doi: 10.1002/jcla.22694.e22694
    1. Sanaei Dashti A., Alizadeh S., Karimi A., Khalifeh M., Shoja S. A. Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis. Medicine . 2017;96(35) doi: 10.1097/md.0000000000007637.e7637
    1. Ljungström L., Pernestig A. K., Jacobsson G., Andersson R., Usener B., Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One . 2017;12(7) doi: 10.1371/journal.pone.0181704.e0181704
    1. Bisaria S., Terrigno V., Hunter K., Roy S. Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension. Journal of Primary Care and Community Health . 2020;11 doi: 10.1177/2150132720984426.921837206
    1. Napolitano L. M. Sepsis 2018: definitions and guideline changes. Surgical Infections . 2018;19(2):117–125. doi: 10.1089/sur.2017.278.
    1. Khwannimit B., Bhurayanontachai R., Vattanavanit V. Comparison of the accuracy of three early warning scores with SOFA score for predicting mortality in adult sepsis and septic shock patients admitted to intensive care unit. Heart & Lung . 2019;48(3):240–244. doi: 10.1016/j.hrtlng.2019.02.005.
    1. Kahn F., Tverring J., Mellhammar L., et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department. Shock . 2019;52(6):e135–e145. doi: 10.1097/shk.0000000000001332.
    1. Linder A., Åkesson P., Inghammar M., Treutiger C.-J., Linnér A., Sundén-Cullberg J. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Critical Care . 2012;16(3):p. R90. doi: 10.1186/cc11353.
    1. Kanashvili B., Saganelidze K., Ratiani L. The role of procalcitonin and blood lactic acid values in prognosis of sepsis and septic shock in polytrauma patients. Georgian Medical News . 2018;279:102–107.
    1. Rhodes A., Evans L. E., Alhazzani W. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine . 2017;43(3):304–377.
    1. Khosravani H., Shahpori R., Stelfox H. T., Kirkpatrick A. W., Laupland K. B. Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Critical Care . 2009;13(3):p. R90. doi: 10.1186/cc7918.
    1. Koozi H., Lengquist M., Frigyesi A. C-reactive protein as a prognostic factor in intensive care admissions for sepsis: a Swedish multicenter study. Journal of Critical Care . 2020;56:73–79. doi: 10.1016/j.jcrc.2019.12.009.
    1. Castro A. R., Silva S. O., Soares S. C. The use of high sensitivity C-reactive protein in cardiovascular disease detection. Journal of Pharmacy & Pharmaceutical Sciences . 2018;21(1):496–503. doi: 10.18433/jpps29872.

Source: PubMed

3
Abonneren